Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis

被引：0
|
作者：
Jingjing Gu
Dandan Chen
Zhiqiang Li
Yongliang Yang
Zhaoming Ma
Guanhong Huang
机构：
[1] Lianyungang Second People’s Hospital Affiliated to Bengbu Medical College,
来源：
Archives of Gynecology and Obstetrics | 2022年 / 306卷
关键词：
CD44; /CD24; Breast cancer; Meta-analysis; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1147 / 1160
页数：13
相关论文
共 50 条
  • [41] Dynamic regulation of CD24 and the invasive, CD44posCD24negphenotype in breast cancer cell lines
    Matthew J Meyer
    Jodie M Fleming
    Mustapha A Ali
    Mitchell W Pesesky
    Erika Ginsburg
    Barbara K Vonderhaar
    Breast Cancer Research, 11
  • [42] The distribution of CD44+/CD24-cancer stem cells in breast cancer and its relationship with prognostic factors
    Cabuk, Devrim
    Yetimoglu, Eylem
    Simsek, Turgay
    Gacar, Gulcin
    Subasi, Cansu
    Canturk, Zafer
    Ercin, Cengiz
    Karaoz, Erdal
    Uygun, Kazim
    JOURNAL OF BUON, 2016, 21 (05): : 1121 - 1128
  • [43] CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
    Xin, Xiaoyan
    Zeng, Xianqin
    Gu, Huajian
    Li, Min
    Tan, Huaming
    Jin, Zhishan
    Hua, Teng
    Shi, Rui
    Wang, Hongbo
    SCIENTIFIC REPORTS, 2016, 6
  • [44] Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer
    Buess, Martin
    Rajski, Michal
    Vogel-Durrer, Brigitte M. L.
    Herrmann, Richard
    Rochlitz, Christoph
    NEOPLASIA, 2009, 11 (10): : 987 - 1002
  • [45] CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chen, Shicai
    Song, Xinming
    Chen, Zhihui
    Li, Xinxin
    Li, Mingzhe
    Liu, Haiying
    Li, Jianchang
    PLOS ONE, 2013, 8 (02):
  • [46] CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
    Xiaoyan Xin
    Xianqin Zeng
    Huajian Gu
    Min Li
    Huaming Tan
    Zhishan Jin
    Teng Hua
    Rui Shi
    Hongbo Wang
    Scientific Reports, 6
  • [47] Novel strategy targeting breast cancer stem cells CD44+/CD24-low responsible for breast cancer progression
    Abouelnazar, Fatma A.
    Sultan, Ahmed S.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Metalloprotease-dependent activation of EGFR modulates CD44+/CD24− populations in triple negative breast cancer cells through the MEK/ERK pathway
    Randi Wise
    Anna Zolkiewska
    Breast Cancer Research and Treatment, 2017, 166 : 421 - 433
  • [49] STAT1 promotes radioresistance of CD44+/CD24-/low cells in breast cancer
    Zhan, Jun-fang
    Chen, Long-hua
    Yuan, Ya-wei
    Xie, Guo-zhu
    Sun, Ai-min
    Liu, Ying
    Chen, Zhi-xian
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (04) : 418 - 422
  • [50] Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
    Zhang, Peng
    Zheng, Pan
    Liu, Yang
    FRONTIERS IN GENETICS, 2019, 10
12345